Business, diagnostic imaging  

Philips wins €27 million contract for digital radiography systems in China

30 January 2007

Ningbo, China. Royal Philips Electronics (NYSE: PHG, AEX: PHI) has signed an agreement with Ascent Profit, a leading Chinese medical equipment wholesaler, to supply 200 high-end radiography systems to hospitals in China in a deal worth €27 million.

Through the agreement with Ascent Profit, Chinese hospitals now have access to Philips' DigitalDiagnost and Philips' Essenta DR. These are designed to provide small and medium-sized hospitals with advanced digital X-ray capabilities and more efficient digital image workflow.

"Digital radiography is one of the fastest-growing segments in the Chinese healthcare market," commented Lin Yang Chen, general manager of Ascent Profit. "This agreement means we can provide major hospitals across the country with a sophisticated digital radiography solution, enabling them to raise the quality of diagnosis while increasing the number of patients they can treat."

Growing at rate of approximately 11% each year, the Chinese healthcare market is currently one of the most rapidly expanding in the world. As patient numbers increase so does the pressure on the country's hospitals, which already treat more than double the number of patients of similar facilities in Europe. While China's healthcare facilities seek to increase the quality of care for an increasing number of patients, finding ways to simplify diagnostic procedures and access to patient data becomes more important.

"At Philips we understand that the needs of every market and every customer are different. That's why we work closely with our dealers in China to ensure our world-leading solutions meet the needs of our customers in the fast-growing high-end market in China," said David Jin, CEO, Philips Medical Systems China. "Our recent introduction of economical radiography systems demonstrates our commitment to making advanced equipment for improved patient care available at a price point that will drive broad adoption in emerging markets such as China's."

To top

To top